Nymox Pharmaceutical (NYMXF) Income from Continuing Operations (2017 - 2024)
Nymox Pharmaceutical (NYMXF) recorded Income from Continuing Operations of -$4.28 million in FY2025, compared with -$4.49 million in FY2024.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Income from Continuing Operations (2017 - 2024) Analysis & Trends
Starting with FY2015, Nymox Pharmaceutical's Income from Continuing Operations history includes 11 years.
- The FY2025 figure is the highest annual Income from Continuing Operations since FY2019.
- Per Business Quant data, NYMXF's Income from Continuing Operations was -$4.49 million in FY2024, -$8.84 million in FY2023, -$6.58 million in FY2022 and -$12.54 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Nymox Pharmaceutical | 6.12 Mn | 5.93 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -857,000.00 |
| Sep 30, 2024 | -716,000.00 |
| Dec 31, 2023 | -5.31 Mn |
| Sep 30, 2023 | -1.04 Mn |
| Jun 30, 2023 | -1.11 Mn |
| Mar 31, 2023 | -1.39 Mn |
| Dec 31, 2022 | -1.34 Mn |
| Sep 30, 2022 | -1.49 Mn |
| Jun 30, 2022 | 1.34 Mn |
| Mar 31, 2022 | -5.09 Mn |
| Dec 31, 2021 | -2.81 Mn |
| Sep 30, 2021 | -3.30 Mn |
| Jun 30, 2021 | -3.99 Mn |
| Mar 31, 2021 | -2.44 Mn |
| Dec 31, 2020 | -2.03 Mn |
| Sep 30, 2020 | -4.16 Mn |
| Jun 30, 2020 | -2.94 Mn |
| Mar 31, 2020 | -2.62 Mn |
| Dec 31, 2019 | -2.58 Mn |
| Sep 30, 2019 | -2.55 Mn |
API Access
Nymox Pharmaceutical Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();